期刊文献+

11例妊娠合并抗磷脂综合征孕妇的52次妊娠结局分析 被引量:5

Analysis on the outcomes of pregnancy for 52 times in 11 pregnant women with anti-phospholipid syndrome
原文传递
导出
摘要 目的:分析妊娠合并抗磷脂综合征(antiphospholipid syndrome,APS)与各妊娠并发症及新生儿出生体重、Ap-gar评分和抗体滴度与妊娠结局的关系。方法:回顾性分析温州医学院附属第一医院2005年6月~2011年3月的11例妊娠合并抗磷脂综合征妇女的52次妊娠过程,并与随机抽取的26例非抗磷脂抗体综合征妇女的妊娠情况进行对比。结果:抗体滴度高的APS妇女的早产率明显高于抗体滴度低的APS妇女。APS组孕妇的流产率明显高于非APS组,妊娠并发症如妊娠期高血压疾病、前置胎盘、妊娠合并肝内胆汁淤积等的发病率没有显著高于非APS组,但是胎膜早破的发生率明显增高。APS组孕妇分娩的新生儿出生体重明显低于非APS组。结论:APS易导致孕妇早产及新生儿出生体重降低,危害母儿健康,故及时、合理地诊断与治疗非常重要,尤其是在抗体滴度高的APS孕妇。 Objective:To analyze the relationship between pregnancy combined with anti-phospholipid syndrome(APS),pregnancy complications,neonatal birth weight,Apgar score,and antibody titer and pregnancy outcomes.Methods:The processes of pregnancy for 52 times in 11 pregnant women with APS from the hospital from June 2005 to March 2011 were analyzed retrospectively,then the results were compared with pregnancy situations of 26 pregnant women without APS who were selected randomly.Results:The rate of premature delivery in APS women with high antibody titer was significantly higher than that in APS women with low antibody titer.The abortion rate in APS women was significantly higher than that in non-APS women,the incidence rates of pregnancy complications(hypertensive disorder complicating pregnancy,placenta previa,intrahepatic cholestasis of pregnancy) in APS women were higher than those in non-APS women,but the incidence rate of premature rupture of fetal membrane in APS women was significantly higher than that in non-APS women.The birth weight of neonates born by APS women was significantly lower that of neonates born by non-APS women.Conclusion:APS can easily induce premature delivery of pregnant women and low neonatal birth weight,harm maternal and infantile health,so timely and reasonable diagnosis and treatment are very important,especially among APS pregnant women with high antibody titer.
作者 周晔 黄引平
出处 《中国妇幼保健》 CAS 北大核心 2013年第10期1575-1578,共4页 Maternal and Child Health Care of China
关键词 抗磷脂综合征 早产 抗体滴度 肝素 Anti-phospholipid syndrome Premature delivery Antibody titer Heparin
  • 相关文献

参考文献13

  • 1邱丽华.妊娠合并抗磷脂综合征的诊治[J].中国实用妇科与产科杂志,2010,26(6):415-417. 被引量:2
  • 2Simchen M J, Dultzkt M. High positive antibody titers and ad- verse pregnancy outcome in women with antiphospholipid syn- drome [J] .AOGS, 2011; 90 (12): 1428.
  • 3林莲莲,陈云琴.抗磷脂综合征与妊娠[J].实用妇产科杂志,2008,24(7):390-392. 被引量:10
  • 4Miyakis S, Lockshin MS, Atsumi T et al. International consen- sus statement on an update of the classification criteria for defi- nite antiphospholipid syndrome[J] . J Thromb Haemost, 2006,4 (2): 295.
  • 5Ruffatti A, Calligaro A, Hoxha Aet al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome[J]. Arthritis Care Res ( Hoboken ), 2010, 62 (3): 302.
  • 6Carbillon ML, Uzan A, Kettaneh E et al. Preeclampsia and an- tiphospholipid syndrome[J] . La Revue de M6decine In- terne, 2006, (2) : 111.
  • 7邓宇斌.抗磷脂抗体的共辅因子β_2GPI的研究进展[J].上海免疫学杂志,1997,17(1):61-62. 被引量:8
  • 8Silver RM, Draper ML, Scott JR et al. Clinical consequences of antiphospholipid antibodies: an historic cohort study[J]. Ob- stet Gynecol, 1994, 83 (3): 372.
  • 9Kutteh WH, Ermel LD. A clinical trial for the treatment of an- tiphospholipid antibody - associated recurrent pregnancy loss with lower dose heparin and aspirin[J]. Am J Reprod Immu-nol, 1996, 35 (4): 402.
  • 10Stepbenson MD, Houliban E, of IVIG for treatment of the Tsang Pet al. Concomitant use antiphospholipid antibody syn- drome (APS) when ASA and heparin results in at least one adverse pregnancy outcome[J] . Lupus, 2002, 11 : 694.

二级参考文献13

  • 1林其德,金妍.如何规范习惯性流产的病因筛查及治疗[J].实用妇产科杂志,2005,21(2):72-74. 被引量:19
  • 2徐亮,林其德,汪希鹏,赵爱民.个体化免疫抑制-抗凝疗法在抗心磷脂抗体阳性复发性流产患者治疗中的应用[J].中国实用妇科与产科杂志,2006,22(9):666-668. 被引量:42
  • 3Miyakis S, Lockshin MS, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome [ J ]. J Thromb Haemost, 2006, 4 ( 2 ) : 295-306.
  • 4Martinez-Zamora MA, Tassies D, Carmona F, et al. Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with preg- nancy outcome and thrombosis [ J ]. Am J Reprod Immunol, 2009, 62(6) : 381-389.
  • 5Chou AK, Hsieh SC, Su YN, et al. Neonatal and pregnancy outcome in primary antiphospholipid syndrome: a 10-year experience in one medical center [ J]. Pediatr Neonatol, 2009, 50 (4) : 143-146.
  • 6Bramham K, Hunt B J, Germain S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome [ J ]. Lupus, 2010, 19(1): 58-64.
  • 7Stephenson, MD, Ballem PJ, Tsang P, et al. , Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin [ J ]. J Obstet Gynaecol Can, 2004, 26 ( 8 ) : 729-734.
  • 8Pauzner R, Dulitzki M, Langevitz P, et al. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy [ J ]. Thromb Haemost, 2001, 86(6) : 1379-1384.
  • 9Wang M X,J Immunol,1995年,155卷,1629页
  • 10Gao B,Gene,1993年,126卷,287页

共引文献17

同被引文献54

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部